Temazepam by McKesson Corporation dba SKY Packaging / McKesson Corporation dba RX Pak TEMAZEPAM capsule

Temazepam by

Drug Labeling and Warnings

Temazepam by is a Prescription medication manufactured, distributed, or labeled by McKesson Corporation dba SKY Packaging, McKesson Corporation dba RX Pak. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

  • DOSAGE AND ADMINISTRATION

    While the recommended usual adult dose is 15 mg before retiring, 7.5 mg may be sufficient for some patients, and others may need 30 mg. In transient insomnia, a 7.5 mg dose may be sufficient to improve sleep latency. In elderly or debilitated patients, it is recommended that therapy be initiated with 7.5 mg until individual responses are determined.

  • HOW SUPPLIED

    Product: 63739-231

    NDC: 63739-231-10 10 CAPSULE in a BLISTER PACK / 10 in a BOX, UNIT-DOSE

  • MEDICATION GUIDE

    MEDICATION GUIDE

    Temazepam Capsules, USP CIV

    (teh-MAZ-eh-pam)

    What is the most important information I should know about temazepam capsules?

    • Temazepam capsules are benzodiazepine medicine. Taking benzodiazepines with opioid medicines, alcohol, or other central nervous system depressants (including street drugs) can cause severe drowsiness, breathing problems (respiratory depression), coma and death.
    • After taking temazepam capsules, you may get up out of bed while not being fully awake and do an activity that you do not know you are doing. The next morning, you may not remember that you did anything during the night. You have a higher chance for doing these activities if you drink alcohol or take other medicines that make you sleepy with temazepam capsules. Reported activities include:
      • driving a car (“sleep-driving”)
      • making and eating food
      • talking on the phone
      • having sex
      • sleep-walking

    Call your healthcare provider right away if you find out that you have done any of the above activities after taking temazepam capsules.

    • Do not take temazepam capsules unless you are able to stay in bed a full night (7 to 8 hours) before you must be active again.
    • Do not take more temazepam capsules than prescribed.

    What are temazepam capsules?

    • Temazepam capsules is a prescription sleep medicine. Temazepam capsules is used in adults for the short-term (usually 7 to 10 days) treatment of a sleep problem called insomnia. Symptoms of insomnia include trouble falling asleep and waking up often during the night.
    • Temazepam capsules is a federal controlled substance (C-IV) because it can be abused or lead to dependence. Keep
      Temazepam capsules in a safe place to prevent misuse and abuse. Selling or giving away temazepam capsules may harm others, and is against the law. Tell your healthcare provider if you have ever abused or been dependent on alcohol, prescription medicines or street drugs.
    • It is not known if temazepam capsules is safe and effective in children.
    • It is not known if temazepam capsules is safe and effective for use longer than 2 weeks.

    Do not take temazepam capsules if you:

    • are allergic to temazepam or any of the ingredients in temazepam capsules. See the end of this Medication Guide for a complete list of ingredients in temazepam capsules.

    Before you take temazepam capsules, tell your healthcare provider about all of your medical conditions, including if you:

    • have a history of depression, mental illness or, suicidal thoughts
    • have a history of drug or alcohol abuse or addiction
    • have lung disease or breathing problems
    • are pregnant or plan to become pregnant. Temazepam capsules may cause birth defects or harm your unborn baby.
    • are breastfeeding, or plan to breastfeed. Temazepam capsules may pass through your breast milk and may harm your baby. Talk to your healthcare provider about the best way to feed your baby if you take temazepam capsules.

    Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
    Taking temazepam capsules with certain other medicines can cause side effects or affect how well temazepam capsules or the other medicines work. Do not start or stop other medicines without talking to your healthcare provider.
    Do not take temazepam capsules with other medicines that can make you sleepy unless your healthcare provider tells you to.

    How should I take temazepam capsules?

    • See “What is the most important information I should know about temazepam capsules?”
    • Take temazepam capsules exactly as your healthcare providers tell you to take it. Take temazepam capsules right before you get into bed.
    • Do not take temazepam capsules unless you are able to get a full night’s sleep before you must be active again.
    • If you take too much temazepam capsules or overdose, get emergency treatment right away.

    What should I avoid while taking temazepam capsules?

    • Do not drive, operate machinery, do other dangerous activities or do anything that needs you to be alert until you know how temazepam capsules affects you.
    • You should not drink alcohol while you are taking temazepam capsules.

    What are the possible side effects of temazepam capsules?
    Temazepam capsules may cause serious side effects, including:

    • See “What is the most important information I should know about temazepam capsules?”
    • Withdrawal symptoms. You may have withdrawal symptoms if you stop taking temazepam capsules suddenly. Withdrawal symptoms can be serious and include seizures shakiness, stomach and muscle cramps, vomiting and sweating. Mild withdrawal symptoms include a depressed mood and trouble sleeping. Talk to your healthcare provider about slowly stopping temazepam capsules to avoid withdrawal symptoms.
    • Abnormal thoughts and behavior. Symptoms include more outgoing or aggressive behavior than normal, confusion, agitation, hallucinations, worsening of depression, and suicidal thoughts.
    • Abuse and dependence. Taking temazepam capsules can cause physical and psychological dependence. Physical and psychological dependence is not the same as drug addiction. Your healthcare provider can tell you more about the differences between physical and psychological dependence and drug addiction.
    • Severe allergic reactions. Symptoms include swelling of the tongue or throat, trouble breathing, and nausea and vomiting. Get emergency medical help right away if you have these symptoms after taking temazepam capsules.

    The most common side effects of temazepam capsules include:
     drowsiness    headache
     tiredness    nervousness
     dizziness    nausea

    You may still feel drowsy the next day after taking temazepam capsules. Do not drive or do other dangerous activities after taking temazepam capsules until you feel fully awake.

    These are not all the possible side effects of temazepam capsules. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

    How should I store temazepam capsules?

    • Store temazepam capsules between 68°F to 77°F (20°C to 25°C).
    • Keep temazepam capsules and all medicines out of the reach of children.

    General information about the safe and effective use of temazepam capsules.
    Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use temazepam capsules for a condition for which it was not prescribed. Do not give temazepam capsules to other people, even if they have the same symptoms that you have. It may harm them. You can ask your healthcare provider or pharmacist for information about temazepam capsules that is written for healthcare professionals.

    What are the ingredients in temazepam capsules?

    Active Ingredient: temazepam, USP

    Inactive Ingredients: corn starch, hypromellose, lactose monohydrate, magnesium stearate, and sodium lauryl sulfate. The capsule shells and imprinting inks contain: benzyl alcohol, butylparaben, edetate calcium disodium, gelatin, iron oxide black, methylparaben, potassium hydroxide, propylene glycol, propylparaben, shellac, sodium lauryl sulfate, sodium propionate, strong ammonia solution and titanium dioxide. The 15 mg capsules also contain D&C Yellow #10 and FD&C Blue #1.

    Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

    This Medication Guide has been approved by the U.S. Food and Drug Administration.

    For Medication Guides, please visit www.us.sandoz.com or call 1-800-507-2130.

    Manufactured by

    Sandoz Inc.

    Princeton, NJ 08540

    7205

    Rev. February 2019

  • Temazepam

    Label Image
  • INGREDIENTS AND APPEARANCE
    TEMAZEPAM 
    temazepam capsule
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC: 63739-231(NDC:0781-2201)
    Route of AdministrationORALDEA ScheduleCIV    
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    TEMAZEPAM (UNII: CHB1QD2QSS) (TEMAZEPAM - UNII:CHB1QD2QSS) TEMAZEPAM15 mg
    Inactive Ingredients
    Ingredient NameStrength
    AMMONIA (UNII: 5138Q19F1X)  
    BENZYL ALCOHOL (UNII: LKG8494WBH)  
    BUTYLPARABEN (UNII: 3QPI1U3FV8)  
    D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  
    EDETATE CALCIUM DISODIUM (UNII: 25IH6R4SGF)  
    FD&C BLUE NO. 1 (UNII: H3R47K3TBD)  
    FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
    GELATIN, UNSPECIFIED (UNII: 2G86QN327L)  
    HYPROMELLOSE 2910 (3 MPA.S) (UNII: 0VUT3PMY82)  
    LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    METHYLPARABEN (UNII: A2I8C7HI9T)  
    POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    PROPYLPARABEN (UNII: Z8IX2SC1OH)  
    SHELLAC (UNII: 46N107B71O)  
    SODIUM LAURYL SULFATE (UNII: 368GB5141J)  
    SODIUM PROPIONATE HYDRATE (UNII: DK6Y9P42IN)  
    STARCH, CORN (UNII: O8232NY3SJ)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    Product Characteristics
    ColorGREEN (green & white) Scoreno score
    ShapeCAPSULESize16mm
    FlavorImprint Code GG531
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC: 63739-231-1010 in 1 BOX, UNIT-DOSE02/27/2007
    110 in 1 BLISTER PACK; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA07142701/12/1988
    Labeler - McKesson Corporation dba SKY Packaging (140529962)
    Establishment
    NameAddressID/FEIBusiness Operations
    McKesson Corporation dba RX Pak025183281REPACK(63739-231)

  • © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.